Scientists Find Weak Spot in Polio and Cold Viruses

Scientists at the University of Maryland, Baltimore County just uncovered a molecular trick that dangerous viruses use to multiply inside our bodies, and it might be their downfall.

The team discovered how enteroviruses, the family behind polio, encephalitis, myocarditis, and even common colds, flip a tiny molecular switch to start copying themselves. This switch, a cloverleaf shaped structure in the virus's genetic code, recruits both viral and human proteins to build the copying machinery the virus needs to spread.

Associate professor Deepak Koirala led the research with recent Ph.D. graduate Naba Krishna Das. Using powerful imaging techniques, they watched how a special viral protein called 3CD locks onto the cloverleaf structure and acts like a power button for virus reproduction.

The discovery solves a puzzle scientists have debated for years. The team proved that two complete 3CD proteins sit side by side on the viral RNA, not fused together as earlier research suggested. When these proteins attach, the virus copies itself. When they let go, the virus makes proteins instead.

Here's what makes this discovery so exciting: the researchers tested seven different enteroviruses and found they all use almost identical cloverleaf structures. That means this weakness is fundamental to how these viruses survive.

The Bright Side

Because the mechanism works the same way across multiple viruses, scientists could develop drugs that target many diseases at once instead of creating separate treatments for each illness. Imagine one antiviral that fights polio, certain heart inflammations, and severe colds all together.

Researchers are already working on drugs that disrupt the 3CD protein itself. Now they have another approach: targeting the cloverleaf structure or blocking where it connects with proteins. Having multiple attack strategies increases the chances of finding treatments that actually work.

The high resolution images from this study give drug developers a precise blueprint for designing molecules that interfere with viral replication. It's like having the enemy's instruction manual.

Koirala marvels at how sophisticated these tiny invaders are despite having genomes equivalent to just one human gene sequence. Understanding their cleverness helps scientists outsmart them.

This research brings us closer to broad spectrum antivirals that could protect people from entire families of dangerous viruses at once.